The invention relates to a composition for the topical treatment and care of psoriatic skin. It consists exclusively of natural substances and comprises at the most peanut oil, olive oil, castor oil, avocado oil, rose oil, rose hydrolate, lanolin and phytosterol in the form of a mixture of at least peanut oil, olive oil, castor oil and lanolin.

The invention relates to a composition for the topical treatment and care of psoriatic skin. It consists exclusively of natural substances and comprises at the most peanut oil, olive oil, castor oil, avocado oil, rose oil, rose hydrolate, lanolin and phytosterol in the form of a mixture of at least peanut oil, olive oil, castor oil and lanolin.

A multi-unit pharmaceutical composition comprising an immediate release component comprising a polyphenol-containing Aspalathus linearis extract and one or more pharmaceutically acceptable excipients, and a sustained release component comprising a polyphenol-containing Aspalathus linearis extract and one or more pharmaceutically acceptable excipients, wherein the composition provides a substantially linear polyphenol release profile over a predetermined period, for example about 8 hours.

A multi-unit pharmaceutical composition comprising an immediate release component comprising a polyphenol-containing Aspalathus linearis extract and one or more pharmaceutically acceptable excipients, and a sustained release component comprising a polyphenol-containing Aspalathus linearis extract and one or more pharmaceutically acceptable excipients, wherein the composition provides a substantially linear polyphenol release profile over a predetermined period, for example about 8 hours.

A unit dosage of an oral composition of an extract of Withania somnifera is disclosed. The extract of Withania somnifera includes total withanolides. The total withanolides includes withanolide glycosides and withanolide aglycones. The extract of Withania somnifera includes about 32% to about 38% by weight of the withanolide glycosides. Methods of preparing the extract of Withania somnifera are disclosed. Methods of treatment by administering the extract of Withania somnifera are disclosed.

A unit dosage of an oral composition of an extract of Withania somnifera is disclosed. The extract of Withania somnifera includes total withanolides. The total withanolides includes withanolide glycosides and withanolide aglycones. The extract of Withania somnifera includes about 32% to about 38% by weight of the withanolide glycosides. Methods of preparing the extract of Withania somnifera are disclosed. Methods of treatment by administering the extract of Withania somnifera are disclosed.

The invention provides a fenugreek extract composition containing at least one of diosgenin, gitogenin, sarsasapogenin, dioscin, protodioscin, pseudoprotodioscin, apigenin or a derivative thereof, luteolin or a derivative thereof, nicotinic acid or a derivative thereof, and kaempferol, or a salt or solvate of any one thereof. Also provided are processes of preparing the extract composition, and nutraceutical and pharmaceutical compositions containing the extract composition.

The invention provides a fenugreek extract composition containing at least one of diosgenin, gitogenin, sarsasapogenin, dioscin, protodioscin, pseudoprotodioscin, apigenin or a derivative thereof, luteolin or a derivative thereof, nicotinic acid or a derivative thereof, and kaempferol, or a salt or solvate of any one thereof. Also provided are processes of preparing the extract composition, and nutraceutical and pharmaceutical compositions containing the extract composition.

Provided is a novel functional composition having an excellent beneficial effect on memory-learning ability that can also be utilized in the form of a food or beverage, etc. Phosphatidylinositol is used as an active ingredient of an oral composition for improving memory-learning ability. The phosphatidylinositol is preferably derived from soybeans. This composition can be used suitably in the form of a food or beverage, food additive, pharmaceutical, supplement, animal feed, etc.

Disclosed is an edible, discontinuous gummy delivery system comprising collagen peptide particles with an average particle size from 5 to 500 μm and an average molecular weight from 1,000 to 10,000 Da dispersed in an elastic matrix, wherein the collagen peptide particles are undissolved or no more than partially dissolved in the elastic matrix, and wherein the collagen peptide particles are present in an amount from 8 to 45% of a total mass of the delivery system. Methods of preparing the gummy delivery systems are also disclosed.